bpc-157 safety human use fda status 2026 July Peptide Meeting: What Patients Need to Know About Access, Approval, and 2026 FDA Peptide Reclassification |

Elevated PSA expected at physiological testosterone levels and monitored routinely

If you have any of these symptoms, ter Keurs recommends speaking to your Primary Care Provider or scheduling a B12 blood test

What they found: Mean weight loss: 2.6 kg vs 2.3 kg placebo , a difference of only 0.3 kg (1 %) Statistically non-significant Clinically unsatisfactory for the obesity indication Safety profile remained favorable Why it matters: The study stopped the development of AOD-9604 as a drug

GLP-1 medications work by mimicking the GLP-1 hormone, which slows gastric emptying, signals satiety to the brain, and helps regulate blood sugar